Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yi Ning, Xiaoqi Wang, Pingan Chen, Shiwu Liu, Jue Hu, Rong Xiao, Ling Li & Fangguo Lu. (2022) Targeted inhibition of methicillin-resistant Staphylococcus aureus biofilm formation by a graphene oxide-loaded aptamer/berberine bifunctional complex. Drug Delivery 29:1, pages 1675-1683.
Read now
Read now
Lorenzo Ferro Desideri, Carlo Enrico Traverso & Massimo Nicolò. (2022) The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases. Expert Opinion on Therapeutic Targets 26:2, pages 145-154.
Read now
Read now
Santiago Grijalvo, Anna Aviñó & Ramon Eritja. (2014) Oligonucleotide delivery: a patent review (2010 – 2013). Expert Opinion on Therapeutic Patents 24:7, pages 801-819.
Read now
Read now
Jean Pierre Hubschman, Shantan Reddy & Steven D Schwartz. (2009) Age-related macular degeneration: current treatments. Clinical Ophthalmology 3, pages 155-166.
Read now
Read now
Sinéad M Ryan, Giuseppe Mantovani, Xuexuan Wang, David M Haddleton & David J Brayden. (2008) Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opinion on Drug Delivery 5:4, pages 371-383.
Read now
Read now
Articles from other publishers (40)
Ambra Giannetti, Barbara Adinolfi & Sara Tombelli. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy
21
50
.
Ajmal Ahmad & Mohd Imtiaz Nawaz. (2022) Molecular mechanism of VEGF and its role in pathological angiogenesis. Journal of Cellular Biochemistry 123:12, pages 1938-1965.
Crossref
Crossref
Parisa Shamshiripour, Fahimeh Hajiahmadi, Shahla Lotfi, Niloofar Robab Esmaeili, Amir Zare, Mahzad Akbarpour & Davoud Ahmadvand. (2022) Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside. Frontiers in Immunology 13.
Crossref
Crossref
James Michael Sutton, Jaeah Kim, Noha M. El Zahar & Michael G. Bartlett. (2020) BIOANALYSIS AND BIOTRANSFORMATION OF OLIGONUCLEOTIDE THERAPEUTICS BY LIQUID CHROMATOGRAPHY‐MASS SPECTROMETRY. Mass Spectrometry Reviews 40:4, pages 334-358.
Crossref
Crossref
Zhili Tian, Guohui Liang, Kunli Cui, Yayu Liang, Qun Wang, Shuangyu Lv, Xiaoxia Cheng & Lei Zhang. (2021) Insight Into the Prospects for RNAi Therapy of Cancer. Frontiers in Pharmacology 12.
Crossref
Crossref
Zhenbao Liu & Yanfei Liu. 2021. Aptamers for Medical Applications. Aptamers for Medical Applications
77
113
.
Yi Ning, Jue Hu & Fangguo Lu. (2020) Aptamers used for biosensors and targeted therapy. Biomedicine & Pharmacotherapy 132, pages 110902.
Crossref
Crossref
N. M. El Zahar, N. Magdy, A. M. El‐Kosasy & Michael G. Bartlett. (2017) Chromatographic approaches for the characterization and quality control of therapeutic oligonucleotide impurities. Biomedical Chromatography 32:1.
Crossref
Crossref
Chui Ming Gemmy Cheung, Jennifer J. Arnold, Frank G. Holz, Kyu Hyung Park, Timothy Y.Y. Lai, Michael Larsen, Paul Mitchell, Kyoko Ohno-Matsui, Shih-Jen Chen, Sebastian Wolf & Tien Yin Wong. (2017) Myopic Choroidal Neovascularization. Ophthalmology 124:11, pages 1690-1711.
Crossref
Crossref
Rui Zhang, Xin Sun & Bo Niu. (2017) The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy. Experimental and Therapeutic Medicine.
Crossref
Crossref
Chiara M. Eandi, Camilla Alovisi, Ugo De Sanctis & Federico M. Grignolo. (2016) Treatment for neovascular age related macular degeneration: The state of the art. European Journal of Pharmacology 787, pages 78-83.
Crossref
Crossref
Robert Hennig, Anika Veser, Susanne Kirchhof & Achim Goepferich. (2015) Branched Polymer–Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors. Molecular Pharmaceutics 12:9, pages 3292-3302.
Crossref
Crossref
Onat Kadioglu, Anna Helena Malczyk, Henry Johannes Greten & Thomas Efferth. (2015) Aptamers as a novel tool for diagnostics and therapy. Investigational New Drugs 33:2, pages 513-520.
Crossref
Crossref
Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard & Francesco Bandello. (2014) Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). British Journal of Ophthalmology 98:9, pages 1144-1167.
Crossref
Crossref
Kai Januschowski, Sven Schnichels, Ulrike Hagemann, Vanessa Koch, Johanna Hofmann, Martin S. Spitzer, Karl-Ulrich Bartz-Schmidt, Peter Szurman, Matthias Lüke & Sabine Aisenbrey. (2014) Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model. Acta Ophthalmologica 92:4, pages e305-e311.
Crossref
Crossref
Yi Kong, Hao Chen, Yong-Qing Wang, Ling Meng & Ji-Fu Wei. (2014) Direct thrombin inhibitors: Patents 2002-2012 (Review). Molecular Medicine Reports.
Crossref
Crossref
Jenny Ibach, Laura Dietrich, Kyra R.M. Koopmans, Nico Nöbel, Marc Skoupi & Susanne Brakmann. (2013) Identification of a T7 RNA polymerase variant that permits the enzymatic synthesis of fully 2′-O-methyl-modified RNA. Journal of Biotechnology 167:3, pages 287-295.
Crossref
Crossref
So Jin Lee, Sejin Son, Ji Young Yhee, Kuiwon Choi, Ick Chan Kwon, Sun Hwa Kim & Kwangmeyung Kim. (2013) Structural modification of siRNA for efficient gene silencing. Biotechnology Advances 31:5, pages 491-503.
Crossref
Crossref
Ravi S. J. Singh & Judy E. Kim. (2012) Ocular Hypertension Following Intravitreal Anti-vascular Endothelial Growth Factor Agents. Drugs & Aging 29:12, pages 949-956.
Crossref
Crossref
Lucian Del Priore, Henry Kaplan, George Magrath & Tongalp Tezel. 2012. Age-Related Macular Degeneration, Third Edition. Age-Related Macular Degeneration, Third Edition
334
353
.
Jin-Wei Cheng, Shi-Wei Cheng, Guo-Cai Lu & Rui-Li Wei. (2012) Effect of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy on the Risk of Arterial Thromboembolic Events: A Meta-Analysis. PLoS ONE 7:7, pages e41325.
Crossref
Crossref
Ryszard Kole, Adrian R. Krainer & Sidney Altman. (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nature Reviews Drug Discovery 11:2, pages 125-140.
Crossref
Crossref
Cynthia L. Stevenson, Christopher A. Rhodes & Steven J. Prestrelski. 2012. Long Acting Injections and Implants. Long Acting Injections and Implants
409
427
.
Jagat R. Kanwar, Ganesh Mahidhara & Rupinder K. Kanwar. (2011) Antiangiogenic therapy using nanotechnological-based delivery system. Drug Discovery Today 16:5-6, pages 188-202.
Crossref
Crossref
Mingshi Yang & Sven Frokjaer. 2009. Delivery Technologies for Biopharmaceuticals. Delivery Technologies for Biopharmaceuticals
9
28
.
Karl Csaky & Diana V. Do. (2009) Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies. American Journal of Ophthalmology 148:5, pages 647-656.
Crossref
Crossref
Beatrix Feigl. (2009) Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis. Progress in Retinal and Eye Research 28:1, pages 63-86.
Crossref
Crossref
M. Stur. (2008) Indikationen für photodynamische Therapie mit Verteporfin im Zeitalter der intravitrealen Therapie – eine ÜbersichtIndications for photodynamic therapy with verteporfin in the age of intravitreal therapy – a review. Spektrum der Augenheilkunde 22:6, pages 340-347.
Crossref
Crossref
Satyanarayana S Vedula & Quan D Nguyen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Lucian Del Priore, Henry Kaplan & Tongalp Tezel. 2007. Age-Related Macular Degeneration, Second Edition. Age-Related Macular Degeneration, Second Edition
329
348
.
Andreas Stahl, Hansjürgen Agostini, Lutz L. Hansen & Nicolas Feltgen. (2007) Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefe's Archive for Clinical and Experimental Ophthalmology 245:10, pages 1429-1436.
Crossref
Crossref
Sarika Verma, Gregory M. Watt, Zhiming Mai & Tayyaba Hasan. (2007) Strategies for Enhanced Photodynamic Therapy Effects. Photochemistry and Photobiology 83:5, pages 996-1005.
Crossref
Crossref
Ursula M. Schmidt-Erfurth, Gisbert Richard, Albert Augustin, William G. Aylward, Francesco Bandello, Borja Corcòstegui, José Cunha-Vaz, Alain Gaudric, Anita Leys & Rainier O. Schlingemann. (2007) Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmologica Scandinavica 85:5, pages 486-494.
Crossref
Crossref
Ursula M. Schmidt-Erfurth & Christian Pruente. (2007) Management of neovascular age-related macular degeneration. Progress in Retinal and Eye Research 26:4, pages 437-451.
Crossref
Crossref
Andrew C.G. Steffensmeier, Antoine E. Azar, Jeffrey J. Fuller, Barbara A. Muller & Stephen R. Russell. (2007) Vitreous Injections of Pegaptanib Sodium Triggering Allergic Reactions. American Journal of Ophthalmology 143:3, pages 512-513.
Crossref
Crossref
M.-H. Teiten, R. Blasius, F. Morceau, M. Diederich & M. Dicato. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
189
214
.
Paula E. BurmeisterChunhua WangJason R. KilloughScott D. LewisLillian R. HorwitzAlicia FergusonKristin M. ThompsonP. Shannon PendergrastThomas G. McCauleyMarkus KurzJohn DienerSharon T. CloadCharles WilsonAnthony D. Keefe. (2006) 2´-Deoxy Purine, 2´-O-Methyl Pyrimidine (dRmY) Aptamers as Candidate Therapeutics. Oligonucleotides 16:4, pages 337-351.
Crossref
Crossref
Peter E. Liggett, Juner Colina, Nauman A. Chaudhry, David Tom & Gregory Haffner. (2006) Triple Therapy of Intravitreal Triamcinolone, Photodynamic Therapy, and Pegaptanib Sodium for Choroidal Neovascularization. American Journal of Ophthalmology 142:6, pages 1072-1074.
Crossref
Crossref
Peter Porschewski, Mira A.-M. Grättinger, Kerstin Klenzke, Anja Erpenbach, Michael R. Blind & Frank Schäfer. (2006) Using Aptamers as Capture Reagents in Bead-Based Assay Systems for Diagnostics and Hit Identification. SLAS Discovery 11:7, pages 773-781.
Crossref
Crossref
U. Schmidt-Erfurth, A. Aue, M. Georgopoulos, C. Kiss, R. Michels, S. Richter-Müksch, S. Sacu, C. Simader, C. Vécsei, P. -V. Vécsei-Marlovits, J. Wagner & S. Michels. (2005) Anti-Angiogenese bei neovaskulärer Makuladegeneration: Neue therapeutische StrategienAntiangiogenesis in neovascular macular degeneration: New therapeutical strategies. Spektrum der Augenheilkunde 19:6, pages 317-325.
Crossref
Crossref